Pulmonary Procedures |

The Role of EBUS-TBNA for the Diagnosis of Sarcoidosis FREE TO VIEW

Rosa Cordovilla, PhD; Aldo Torracchi, MD; Gonzalo Varela Simó, PhD; Maria Asuncion Gomez, MD; José María González-Ruiz, PhD; Marcelo Fernando Jiménez López, PhD; Manuel Lanchas, MBBS; Miguel Barrueco, PhD
Author and Funding Information

Salamanca University Hospital, Salamanca, Spain

Chest. 2014;145(3_MeetingAbstracts):498A. doi:10.1378/chest.1824354
Text Size: A A A
Published online


SESSION TITLE: Bronchoscopy & Interventional Procedures

SESSION TYPE: Slide Presentations

PRESENTED ON: Monday, March 24, 2014 at 09:00 AM - 10:30 AM

PURPOSE: Transbronchial and endobronchial biopsies are recommended as initial procedures for the diagnosis of pulmonary sarcoidosis. After emerging EBUS-TBNA, the diagnosis of indeterminate mediastinal lymph nodes with clinical suspicious of sarcoidosis might be challenging. In this report, we analyze the accuracy of EBUS-TBNA in the diagnosis of sarcoidosis and the influence of different factors in the diagnostic yield.

METHODS: We reviewed the cytopathologic reports of a series of 49 cases of benign Lymph nodes in which diagnosis was performed by EBUS. All patients had enlarged hilar and/or mediastinal LN in chest CT. We performed EBUS-TBNA under conscious sedation with 21 or 22 G needle and with or without ROSE. The gold standard was the histological study of lymph nodes made by mediastinoscopy if the results of EBUS-TBNA were negative.

RESULTS: EBUS-TBNA confirmed a diagnosis of sarcoidosis in 28 of the 49 patients (57%) by identifying non-caseating epitheliod cell granulomas. The remaining 21 patients were diagnosed by mediastinoscopy, 10 patients as sarcoidosis and 9 patients as non-specific benign LN. None of these patients had a high clinical suspicion of sarcoidosis. So, the diagnostic yield in patients with clinical suspicious of sarcoidosis was higher than in patients without it (66% vs 27%). The sensitivity of EBUS-TBNA was 74% and the diagnostic accuracy was 79%. ROSE did not improve the diagnostic yield but the results were better with 21G needle than with 22G needle (75% vs 54%). The mean size of the enlarged LN, as measured by EBUS, was 12.8 mm, and higher in sarcoidosis LN than non-sarcoidosis LN (15.3 mm vs 11.5 mm).

CONCLUSIONS: EBUS-TBNA is a useful tool for diagnosis of sarcoidosis and might be the first step in the diagnosis of sarcoidosis if hilar LN are present. The pre-test probability is an important influence in the diagnostic yield of EBUS for the diagnosis of sarcoidosis.

CLINICAL IMPLICATIONS: EBUS-TBNA may be considered to be a first procedure when the patient has suspected sarcoidosis with mediastinal lymph nodes.

DISCLOSURE: The following authors have nothing to disclose: Rosa Cordovilla, Aldo Torracchi, Gonzalo Varela Simó, Maria Asuncion Gomez, José María González-Ruiz, Marcelo Fernando Jiménez López, Manuel Lanchas, Miguel Barrueco

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543